SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-20-008838
Filing Date
2020-04-29
Accepted
2020-04-29 16:28:29
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dffn20200427_defa14a.htm DEFA14A 14848
2 n1.jpg GRAPHIC 76252
3 n2.jpg GRAPHIC 111032
4 n3.jpg GRAPHIC 41151
5 n4.jpg GRAPHIC 16468
  Complete submission text file 0001437749-20-008838.txt   353880
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37942 | Film No.: 20830750
SIC: 2834 Pharmaceutical Preparations